株式会社極東書店トップ商品一覧Neurodegenerative Diseases: Molecular and Cellular Mechanisms and Therapeutic Advances. Softcover reprint of the original 1st ed. 1996

商品詳細

Neurodegenerative Diseases: Molecular and Cellular Mechanisms and Therapeutic Advances. Softcover reprint of the original 1st ed. 1996

Neurodegenerative Diseases: Molecular and Cellular Mechanisms and Therapeutic Advances. Softcover reprint of the original 1st ed. 1996

・ISBN 978-1-4899-0211-5 paper EUR 199.99

¥53,456.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
著者・編者Fiskum, Gary (ed.),
シリーズ (Gwumc Department of Biochemistry and Molecular Biology Annual Spring Symposia)
出版社 (Springer-Verlag New York Inc., US)
出版年月2013
ページ数482 pp.
言語ENG
ニュース番号<A04-77521>

解説

This book presents much of the exciting new information on mechanisms of neurodegenerative disorders that was presented at the XVth International Spring Symposium on Health Sciences at George Washington University in Washington, D.C. The organization of the symposium as weIl as the chapters within this book were based upon fundamental molecular and cellular mechanisms of neurodegeneration rather than upon different clinically defined disorders, in order to emphasize the commonality of cause rather than effect. The first part of the book is devoted to the relationships between selective vulnerability of different neuronal cell types to injury and their functional characteristics related to the transport, binding, and responses for excitatory amino acids, e.g., glutamate, as weIl as other neurotransmitters involved in toxicity. These relationships are studied in the context of neurodegeneration associated with several disorders including Parkinson's disease, amyotrophic lateral sclerosis (ALS), cerebral ischemia, and AIDS dementia. Part 11 emphasizes the role of amyloid proteins in neurodegeneration but also covers other molecular and genetic risk factors, e.g., expression of different apo lipoprotein isoforms and the involvement of abnormal superoxide dismutase in neuropathology. These topics are applied primarily to the aging brain, Alzheimer's disease, and ALS.